Understanding sex differences in physiology and disease requires the identification of the molecular agents that cause phenotypic sex differences. Two groups of such agents are genes located on the sex chromosomes, and gonadal hormones. The former have coherent linkage to chromosomes that form differently in the two sexes under the influence of genomic forces that are not related to reproductive function, whereas the latter have a direct or indirect relationship to reproduction. Evidence published in the past 5 years supports the identification of several agents of sexual differentiation encoded by the X chromosome in mice, including Kdm5c, Kdm6a, Ogt and Xist. These X chromosome agents have wide pleiotropic effects, potentially influencing sex differences in many different tissues, a characteristic shared with the gonadal hormones. The identification of X chromosome agents of sexual differentiation will facilitate understanding of complex intersecting gene pathways underlying sex differences in disease.
Phenotypic sex differences arise because of the different expression levels of genes on the sex chromosomes, including unequal downstream effects of gonadal hormones.
Evidence in the past 5 years implicates specific X chromosome genes as agents causing sex differences in a wide variety of tissues, which is relevant to many diseases.
Two major groups of agents of sexual differentiation, sex chromosome genes and gonadal hormones, might differ in their relevance to reproduction because of their different evolutionary history and chromosomal linkage.
Sex-biasing effects of sex chromosome genes and gonadal hormones might be favoured because they produce a de novo adaptive effect or offset another disadvantageous sex difference.
Because gonadal hormonal and sex chromosomal agents of sexual differentiation both have pleiotropic effects, they probably produce diverse sex differences that are not all equally advantageous.
Sex differences in disease might occur even in tissues that function equally in healthy individuals, if the sex difference is based on different compensatory mechanisms in the two sexes.
This is a preview of subscription content, access via your institution
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Clayton, J. A. & Collins, F. S. Policy: NIH to balance sex in cell and animal studies. Nature 509, 282–283 (2014).
De Vries, G. J. Minireview: Sex differences in adult and developing brains: compensation, compensation, compensation. Endocrinology 145, 1063–1068 (2004).
Arnold, A. P. The end of gonad-centric sex determination in mammals. Trends Genet. 28, 55–61 (2012).
Arnold, A. P. Sexual differentiation of brain and other tissues: five questions for the next 50 years. Horm. Behav. 120, 104691 (2020).
Jost, A. Hormonal factors in the sex differentiation of the mammalian foetus. Philos. Trans. Roy. Soc. Lond. B Biol. Sci. 259, 119–130 (1970).
Phoenix, C. H., Goy, R. W., Gerall, A. A. & Young, W. C. Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Endocrinology 65, 369–382 (1959).
Arnold, A. P. The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm. Behav. 55, 570–578 (2009).
Lowe, R., Gemma, C., Rakyan, V. K. & Holland, M. L. Sexually dimorphic gene expression emerges with embryonic genome activation and is dynamic throughout development. BMC Genomics 16, 295 (2015).
Werner, R. J. et al. Sex chromosomes drive gene expression and regulatory dimorphisms in mouse embryonic stem cells. Biol. Sex. Differ. 8, 28 (2017).
Bellott, D. W. et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature 508, 494–499 (2014).
Cooke, B., Hegstrom, C. D., Villeneuve, L. S. & Breedlove, S. M. Sexual differentiation of the vertebrate brain: principles and mechanisms. Front. Neuroendocrinol. 19, 323–362 (1998).
Arnold, A. P. Rethinking sex determination of non-gonadal tissues. Curr. Top. Dev. Biol. 134, 289–315 (2019).
Fang, H., Deng, X. & Disteche, C. M. X-factors in human disease: impact of gene content and dosage regulation. Hum. Mol. Genet. 30, R285–R295 (2021).
Naqvi, S. et al. Conservation, acquisition, and functional impact of sex-biased gene expression in mammals. Science 365, eaaw7317 (2019).
Capel, B. Vertebrate sex determination: evolutionary plasticity of a fundamental switch. Nat. Rev. Genet. 18, 675–689 (2017).
Disteche, C. M. Dosage compensation of the sex chromosomes and autosomes. Semin. Cell Dev. Biol. 56, 9–18 (2016).
Hughes, J. F. & Page, D. C. The biology and evolution of mammalian Y chromosomes. Annu. Rev. Genet. 49, 507–527 (2015).
Chaligne, R. & Heard, E. X-chromosome inactivation in development and cancer. Febs. Lett. 588, 2514–2522 (2014).
Yildirim, E. et al. Xist RNA is a potent suppressor of hematologic cancer in mice. Cell 152, 727–742 (2013).
Graves, J. A. M. Sex chromosome specialization and degeneration in mammals. Cell 124, 901–914 (2006).
Dunford, A. et al. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat. Genet. 49, 10–16 (2017).
Rubin, J. B. et al. Sex differences in cancer mechanisms. Biol. Sex. Differ. 11, 17 (2020).
Arnold, A. P. Four core genotypes and XY* mouse models: update on impact on SABV research. Neurosci. Biobehav. Rev. 119, 1–8 (2020).
Burgoyne, P. S. & Arnold, A. P. A primer on the use of mouse models for identifying direct sex chromosome effects that cause sex differences in non-gonadal tissues. Biol. Sex. Differ. 7, 68 (2016).
Cunningham, C. M. et al. Y-chromosome gene, Uty, protects against pulmonary hypertension by reducing lung pro-inflammatory cytokines. FASEB J. https://doi.org/10.1096/fasebj.2020.34.s1.02378 (2020).
Link, J. C. et al. X chromosome dosage of histone demethylase KDM5C determines sex differences in adiposity. J. Clin. Invest. 130, 5688–5702 (2020).
Migeon, B. R. Females are Mosaics: X Inactivation and Sex Differences in Disease (Oxford Univ. Press, 2007).
Charlesworth, B. & Charlesworth, D. The degeneration of Y chromosomes. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355, 1563–1572 (2000).
Bachtrog, D. Y-chromosome evolution: emerging insights into processes of Y-chromosome degeneration. Nat. Rev. Genet. 14, 113–124 (2013).
Charlesworth, D., Charlesworth, B. & Marais, G. Steps in the evolution of heteromorphic sex chromosomes. Heredity 95, 118–128 (2005).
Cotton, A. M. et al. Analysis of expressed SNPs identifies variable extents of expression from the human inactive X chromosome. Genome Biol. 14, R122 (2013).
Berletch, J. B. et al. Escape from X inactivation varies in mouse tissues. PLoS Genet. 11, e1005079 (2015).
Cortez, D. et al. Origins and functional evolution of Y chromosomes across mammals. Nature 508, 488–493 (2014).
Naqvi, S., Bellott, D. W., Lin, K. S. & Page, D. C. Conserved microRNA targeting reveals preexisting gene dosage sensitivities that shaped amniote sex chromosome evolution. Genome Res. 28, 474–483 (2018).
Raznahan, A. et al. Sex-chromosome dosage effects on gene expression in humans. Proc. Natl Acad. Sci. USA 115, 7398–7403 (2018).
Carrel, L. & Willard, H. F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434, 400–404 (2005).
Tukiainen, T. et al. Landscape of X chromosome inactivation across human tissues. Nature 550, 244–248 (2017).
Delbridge, A. R. D. et al. Loss of p53 causes stochastic aberrant X-chromosome inactivation and female-specific neural tube defects. Cell Rep. 27, 442–454 (2019).
Yu, B. et al. B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells. Cell 184, 1790–1803 (2021).
Pessia, E., Makino, T., Bailly-Bechet, M., McLysaght, A. & Marais, G. A. Mammalian X chromosome inactivation evolved as a dosage-compensation mechanism for dosage-sensitive genes on the X chromosome. Proc. Natl Acad. Sci. USA 109, 5346–5351 (2012).
Peeters, S. B., Cotton, A. M. & Brown, C. J. Variable escape from X-chromosome inactivation: identifying factors that tip the scales towards expression. Bioessays 36, 746–756 (2014).
Syrett, C. M. & Anguera, M. C. When the balance is broken: X-linked gene dosage from two X chromosomes and female-biased autoimmunity. J. Leukoc. Biol. 106, 919–932 (2019).
Garieri, M. et al. Extensive cellular heterogeneity of X inactivation revealed by single-cell allele-specific expression in human fibroblasts. Proc. Natl Acad. Sci. USA 115, 13015–13020 (2018).
Golden, L. C. et al. Parent-of-origin differences in DNA methylation of X chromosome genes in T lymphocytes. Proc. Natl Acad. Sci. USA 116, 26779–26787 (2019).
Wijchers, P. J. & Festenstein, R. J. Epigenetic regulation of autosomal gene expression by sex chromosomes. Trends Genet. 27, 132–140 (2011).
Tricarico, R., Nicolas, E., Hall, M. J. & Golemis, E. A. X- and Y-linked chromatin-modifying genes as regulators of sex-specific cancer incidence and prognosis. Clin. Cancer Res. 26, 5567–5578 (2020).
Shpargel, K. B., Sengoku, T., Yokoyama, S. & Magnuson, T. UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development. PLoS Genet. 8, e1002964 (2012).
Godfrey, A. K. et al. Quantitative analysis of Y-chromosome gene expression across 36 human tissues. Genome Res. 30, 860–873 (2020).
Oliva, M. et al. The impact of sex on gene expression across human tissues. Science 369, eaba3066 (2020).
Kelkar, A., Thakur, V., Ramaswamy, R. & Deobagkar, D. Characterisation of inactivation domains and evolutionary strata in human X chromosome through Markov segmentation. PLoS ONE 4, e7885 (2009).
Iwase, S. et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128, 1077–1088 (2007).
Chen, X. et al. The number of X chromosomes causes sex differences in adiposity in mice. PLoS Genet. 8, e1002709 (2012).
Link, J. C. et al. Increased high-density lipoprotein cholesterol levels in mice with XX versus XY sex chromosomes. Arterioscler. Thromb. Vasc. Biol. 35, 1778–1786 (2015).
Kosugi, M. et al. Mutations of histone demethylase genes encoded by X and Y chromosomes, Kdm5c and Kdm5d, lead to noncompaction cardiomyopathy in mice. Biochem. Biophys. Res. Commun. 525, 100–106 (2020).
Venkataramanan, S., Gadek, M., Calviello, L., Wilkins, K. & Floor, S. N. DDX3X and DDX3Y are redundant in protein synthesis. RNA 27, 1577–1588 (2021).
Tran, N., Broun, A. & Ge, K. Lysine demethylase KDM6A in differentiation, development, and cancer. Mol. Cell Biol. 40, e00341-20 (2020).
Kaneko, S. & Li, X. X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism. Sci. Adv. 4, eaar5598 (2018).
Davis, E. J. et al. The second X chromosome confers resilience against Alzheimer’s disease-related deficits in male and female mice. Sci. Transl. Med. 12, eaaz5677 (2020).
Fish, E. N. The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol. 8, 737–744 (2008).
Voskuhl, R. R. & Gold, S. M. Sex-related factors in multiple sclerosis susceptibility and progression. Nat. Rev. Neurol. 8, 255–263 (2012).
Itoh, Y. et al. The X-linked histone demethylase Kdm6a in CD4+ T lymphocytes modulates autoimmunity. J. Clin. Invest. 130, 3852–3863 (2019).
Smith-Bouvier, D. L. et al. A role for sex chromosome complement in the female bias in autoimmune disease. J. Exp. Med. 205, 1099–1108 (2008).
Doss, P. et al. Male sex chromosomal complement exacerbates the pathogenicity of Th17 cells in a chronic model of central nervous system autoimmunity. Cell Rep. 34, 108833 (2021).
Nugent, B. M., O’Donnell, C. M., Epperson, C. N. & Bale, T. L. Placental H3K27me3 establishes female resilience to prenatal insults. Nat. Commun. 9, 2555 (2018).
Howerton, C. L. & Bale, T. L. Targeted placental deletion of OGT recapitulates the prenatal stress phenotype including hypothalamic mitochondrial dysfunction. Proc. Natl Acad. Sci. USA 111, 9639–9644 (2014).
Marahrens, Y., Panning, B., Dausman, J., Strauss, W. & Jaenisch, R. Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes Dev. 11, 156–166 (1997).
Yang, L., Kirby, J. E., Sunwoo, H. & Lee, J. T. Female mice lacking Xist RNA show partial dosage compensation and survive to term. Genes Dev. 30, 1747–1760 (2016).
Yang, L., Yildirim, E., Kirby, J. E., Press, W. & Lee, J. T. Widespread organ tolerance to Xist loss and X reactivation except under chronic stress in the gut. Proc. Natl Acad. Sci. USA 117, 4262–4272 (2020).
Adrianse, R. L. et al. Perturbed maintenance of transcriptional repression on the inactive X-chromosome in the mouse brain after Xist deletion. Epigenetics Chromatin 11, 50 (2018).
Wang, W. et al. Biological function of long non-coding RNA (lncRNA) Xist. Front. Cell Dev. Biol. 9, 645647 (2021).
Wang, C. et al. Silencing of lncRNA XIST impairs angiogenesis and exacerbates cerebral vascular injury after ischemic stroke. Mol. Ther. Nucleic Acids 26, 148–160 (2021).
Chen, X. et al. Sex difference in neural tube defects in p53-null mice is caused by differences in the complement of X not Y genes. Dev. Neurobiol. 68, 265–273 (2008).
Dean, R. & Mank, J. E. The role of sex chromosomes in sexual dimorphism: discordance between molecular and phenotypic data. J. Evol. Biol. 27, 1443–1453 (2014).
The author thanks his many generous collaborators, who have inspired him and educated him concerning concepts discussed here. The author is supported by NIH grants OD030496, OD026560, HD100298, HD076125, DK083561 and HL131182.
The author declares no competing interests.
Peer review information
Nature Reviews Endocrinology thanks Christine Disteche, Adriana Maggi and Margaret McCarthy for their contribution to the peer review of this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Arnold, A.P. X chromosome agents of sexual differentiation. Nat Rev Endocrinol 18, 574–583 (2022). https://doi.org/10.1038/s41574-022-00697-0